Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial

Roger Stupp; Monika E. Hegi; Thierry Gorlia; Sara Erridge; James Perry; Yong-Kil Hong; Kenneth Aldape; Benoît Lhermitte; Torsten Pietsch; Danica Grujičić; Joachim P. Steinbach; Wolfgang Wick; R. Tarnawski; Do‐Hyun Nam; Peter Hau; Astrid Weyerbrock; Martin J B Taphoorn; Chiung‐Chyi Shen; Nalini Rao; László Thurzó; Ulrich Herrlinger; Tejpal Gupta; Rolf‐Dieter Kortmann; Krystyna Adamska; Catherine McBain; Alba A. Brandes; J. C. Tonn; Oliver Schnell; Thomas Wiegel; Chae‐Yong Kim; Burt Nabors; David A. Reardon; Martin J. van den Bent; Christine Hicking; Andriy Markivskyy; Martin Picard; Michael Weller

doi:10.1016/s1470-2045(14)70379-1

Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial

Roger Stupp(University Hospital of Lausanne), Monika E. Hegi(University Hospital of Lausanne), Thierry Gorlia(European Organisation for Research and Treatment of Cancer), Sara Erridge(Edinburgh Cancer Research), James Perry(Sunnybrook Health Science Centre), Yong-Kil Hong(The Catholic University of Korea Seoul St. Mary's Hospital), Kenneth Aldape(The University of Texas MD Anderson Cancer Center), Benoît Lhermitte(University Hospital of Lausanne), Torsten Pietsch(University of Bonn), Danica Grujičić(University of Belgrade), Joachim P. Steinbach(Goethe University Frankfurt), Wolfgang Wick(German Cancer Research Center), R. Tarnawski(The Maria Sklodowska-Curie National Research Institute of Oncology), Do‐Hyun Nam(Samsung Medical Center), Peter Hau(University Hospital Regensburg), Astrid Weyerbrock(University Medical Center Freiburg), Martin J B Taphoorn(Medisch Centrum Haaglanden), Chiung‐Chyi Shen(Taichung Veterans General Hospital), Nalini Rao(Kidwai Memorial Institute of Oncology), László Thurzó(University of Szeged), Ulrich Herrlinger(University of Bonn), Tejpal Gupta(Tata Memorial Hospital), Rolf‐Dieter Kortmann(University Hospital Leipzig), Krystyna Adamska(Greater Poland Cancer Center), Catherine McBain(The Christie Hospital), Alba A. Brandes(Institute of Neurological Sciences), J. C. Tonn(LMU Klinikum), Oliver Schnell(LMU Klinikum), Thomas Wiegel(University Hospital Ulm), Chae‐Yong Kim(Seoul National University Bundang Hospital), Burt Nabors(University of Alabama at Birmingham), David A. Reardon(Dana-Farber Cancer Institute), Martin J. van den Bent(Erasmus MC Cancer Institute), Christine Hicking(Merck (Germany)), Andriy Markivskyy(Merck (Germany)), Martin Picard(Merck (Germany)), Michael Weller(University Hospital of Zurich)

The Lancet Oncology

August 19, 2014

10.1016/s1470-2045(14)70379-1

Cited by 1,017Open Access

Abstract

Related Papers

No related papers found

Powered by citation graph analysis